Logo
Login
$AVTX
$6.75 -$0.02 (0.3%) Close

Company Executives

$AVTX Management Team

Mr. Christopher Sullivan

Chief Financial Officer

Age 41
Compensation $2.930M USD
Sex Male

Dr. Garry Neil

President

Chief Executive Officer

Director

Age 71
Compensation $7.213M USD
Sex Male

Dr. Mittie Doyle

Chief Medical Officer

Age 60
Compensation $3.034M USD
Sex Female

Mr. Michael Heffernan

Independent Chairman of the Board

Age 60
Compensation -
Sex Male

Ms. Jennifer Riley

Chief Strategy Officer

Age 50
Compensation -
Sex Female

Mr. Paul Varki

Chief Legal Officer

Age 52
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 10, 2026
Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
2.4 years
from year joined
CEO also chairs the board
No
Michael Heffernan
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Heffernan
Board chair
 61 2025
1 year
 Independent None stated Biohaven (NYSE: BHVN) $509,578
Garry Neil
CEO
 72 2022
4 years
 Not independent None stated Celldex Therapeutics, Inc. (Nasdaq: CLDX) Paid as CEO
Mitchell Chan Leaving at the meeting
Not stated Not stated Independent
Audit
None stated $133,991
Jonathan Goldman Leaving at the meeting
Not stated Not stated Independent None stated None stated $128,473
Rita Jain
63 2025
1 year
 Independent
Audit
Celldex Therapeutics, Inc. (Nasdaq: CLDX) $177,579
Aaron Kantoff
40 2024
2 years
 Independent None stated None stated $128,973
Gilla Kaplan, Ph.D.
78 2020
6 years
 Independent None stated Tyra Biosciences, Inc. (Nasdaq: TYRA) $126,955
Kevin Lind
50 2025
1 year
 Independent None stated None stated $456,488
Samantha Truex
55 2024
2 years
 Independent None stated None stated $127,473

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

1 disclosed in the proxy filed Apr 10, 2026
Jennifer Riley
Chief Strategy Officer effective January 1, 2025; founder and sole member of Northbrook Consulting, LLC
Approximately $188,000
July 2024 to December 2024

Consulting services provided to the Company through Northbrook Consulting, LLC before Ms. Riley's appointment as Chief Strategy Officer; relationship ended December 31, 2024.

With Northbrook Consulting, LLC Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans